Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Histopathology

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    March 2017
  1. POLONIA A, Eloy C, Pinto J, Braga AC, et al
    Counting invasive breast cancer cells in HER2 silver in situ hybridization test: how many cells are enough?
    Histopathology. 2017 Mar 7. doi: 10.1111/his.13208.
    PubMed     Text format     Abstract available


    November 2016
  2. CHENG KK, Dickson A, Gujam FJ, McMillan DC, et al
    The Relationship between Oestrogen Receptor-alpha Phosphorylation and the Tumour Microenvironment in Patients with Primary Operable Ductal Breast Cancer.
    Histopathology. 2016 Nov 28. doi: 10.1111/his.13134.
    PubMed     Text format     Abstract available


    October 2016
  3. RAKHA EA, Agarwal D, Green AR, Ashankyty I, et al
    Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.
    Histopathology. 2016 Oct 26. doi: 10.1111/his.13108.
    PubMed     Text format     Abstract available


    July 2016
  4. FOCKE CM, Decker T, van Diest PJ
    Reliability of histological grade in breast cancer core needle biopsies depends on biopsy size: a comparative study with subsequent surgical excisions.
    Histopathology. 2016 Jul 15. doi: 10.1111/his.13036.
    PubMed     Text format     Abstract available


    June 2016
  5. BISERNI GB, Engstrom MJ, Bofin AM
    HER2 gene copy number and breast cancer specific survival.
    Histopathology. 2016 Jun 6. doi: 10.1111/his.13010.
    PubMed     Text format     Abstract available


    May 2016
  6. SAI-GIRIDHAR P, Al-Ramadhani S, George D, Gopinath P, et al
    A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patients.
    Histopathology. 2016;68:875-87.
    PubMed     Text format     Abstract available


    March 2016
  7. VAN DORPE J, Hoorens A, Van Roy N, Dedeurwaerdere F, et al
    The challenging differential diagnosis of skin tumours with a rhabdoid phenotype: not all tumours with rhabdoid phenotype belong to the group of SMARCB1-deficient tumours.
    Histopathology. 2016;68:608-12.
    PubMed     Text format    


    February 2016
  8. PARE R, Shin JS, Lee SC
    Increased expression of senescence markers p14 and p16 in breast cancer is associated with increased risk of disease recurrence and poor survival outcome.
    Histopathology. 2016 Feb 4. doi: 10.1111/his.12948.
    PubMed     Text format     Abstract available


    January 2016
  9. KNUTTEL FM, Waaijer L, Merckel LG, van den Bosch MA, et al
    Histopathology of breast cancer after magnetic resonance-guided high intensity focused ultrasound and radiofrequency ablation.
    Histopathology. 2016 Jan 5. doi: 10.1111/his.12926.
    PubMed     Text format     Abstract available


  10. LIN CY, Barry-Holson KQ, Allison KH
    Breast cancer stem cells: are we ready to go from bench to bedside?
    Histopathology. 2016;68:119-37.
    PubMed     Text format     Abstract available


  11. DEB S, Lakhani SR, Ottini L, Fox SB, et al
    The cancer genetics and pathology of male breast cancer.
    Histopathology. 2016;68:110-8.
    PubMed     Text format     Abstract available


  12. KOS Z, Dabbs DJ
    Biomarker assessment and molecular testing for prognostication in breast cancer.
    Histopathology. 2016;68:70-85.
    PubMed     Text format     Abstract available


  13. MAGUIRE A, Brogi E
    Sentinel lymph nodes for breast carcinoma: an update on current practice.
    Histopathology. 2016;68:152-67.
    PubMed     Text format     Abstract available


  14. CALHOUN BC, Collins LC
    Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature.
    Histopathology. 2016;68:138-51.
    PubMed     Text format     Abstract available


    November 2015
  15. BECKERS RK, Selinger CI, Vilain R, Madore J, et al
    PDL1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
    Histopathology. 2015 Nov 20. doi: 10.1111/his.12904.
    PubMed     Text format     Abstract available


  16. RAKHA EA, Pigera M, Shin SJ, D'Alfonso T, et al
    HER2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing?
    Histopathology. 2015 Nov 6. doi: 10.1111/his.12900.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: